Source: Hamilton Devices.
  • Lifeist’s (LFST) CannMart subsidiary has signed a distribution agreement with Hamilton Devices
  • Hamilton is one of the leading U.S. manufacturers and suppliers of vape hardware
  • CannMart is the first distributor of Hamilton products across Canada
  • Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness
  • Lifeist Wellness Inc. (LFST) is holding steady at $0.095 per share

Lifeist’s (LFST) CannMart subsidiary has signed a distribution agreement with Hamilton Devices.

Hamilton is one of the leading U.S. manufacturers and suppliers of vape hardware. It delivers extract-based cannabis products such as distillate, live resin and shatter through industry-wide 510 thread carts. 

CannMart is the first distributor of Hamilton products across Canada. The agreement runs until October 2024 with an initial six months of exclusivity.

CannMart intends to leverage its master distributor status to sell Hamilton products directly into its expanding retail store network of over 2,500 stores across Canada.

Daniel Stern, CEO of CannMart, commented on the news:

“It’s a privilege to be selected by Hamilton Devices as its exclusive B2B distribution partner for Canada. We can’t wait to leverage our established relationships to bring their innovative vaporizer technologies to Canadian consumers.”

CannMart is a Canadian licensed cannabis producer. It operates a B2B wholesale distribution business facilitating recreational cannabis sales to Canadian provincial governments.

Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness.

Lifeist Wellness Inc. (LFST) is holding steady at $0.095 per share as of 1:50 pm ET.


More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

Reliq Health expands contract with U.S. health group

Reliq Health Technologies (TSXV:RHT) reveals it has expanded an existing contract with a large U.S. health group.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.